1Alaa Shehata, 2Yehia El Mashad, 3Amr S.M. El Sayed and 3Baheya Riad
1Egyptian Organization for Biological Products and Vaccines (VACSERA), 2Department of Medical Biochemistry, Tanta University, 3Department of Chemistry, Faculty of Science, Cairo University
Haemophilus influenzae type b (Hib) capsular
polysaccharide (CPS)/ tetanus toxoid (TT) conjugate vaccine has been previously
prepared. At this study chemical binding between CPS and the carrier protein
(TT) was assessed by ELISA using hyper immune burro serum raised against Hib
CPS. The highest reactivity of this hyper immune serum was found to be against
the conjugate when compared to CPS alone, unconjugated CPS + TT mixture and
tyraminated CPS. The immune response against Hib CPS using this conjugate
vaccine was studied in C57Bl/6J mice. Animals injected with two doses of the
conjugate showed better immune response compared to animals injected with CPS.
Also, a boosting effect was noticed after injection of a third dose of the
conjugate which did not occur after third dose of CPS. The conjugate was found
to elicit a level of immune response in mice similar to that elicited by each
of three licensed commercially available Hib CPS conjugate vaccines after two
doses. The same boosting effect was obtained after injection of a third dose of
the conjugate similar to that obtained after injection of a third dose of the
licensed vaccines. These results suggest further studies of this conjugate
vaccine to be used in Egypt.